Equities

Shandong Boan Biotechnology Co Ltd

Shandong Boan Biotechnology Co Ltd

Actions
  • Price (EUR)0.99
  • Today's Change0.005 / 0.51%
  • Shares traded45.00
  • 1 Year change-55.80%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments202233614
Total Receivables, Net293227126
Total Inventory16514499
Prepaid expenses383152
Other current assets, total1521250
Total current assets713847940
Property, plant & equipment, net660624601
Goodwill, net------
Intangibles, net951732566
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets2,3232,2032,107
LIABILITIES
Accounts payable18615394
Accrued expenses17318270
Notes payable/short-term debt1187.1645
Current portion long-term debt/capital leases869220
Other current liabilities, total913832
Total current liabilities653472260
Total long term debt234210245
Total debt438309309
Deferred income tax------
Minority interest------
Other liabilities, total11610350
Total liabilities1,004784555
SHAREHOLDERS EQUITY
Common stock509509499
Additional paid-in capital1,3291,3291,162
Retained earnings (accumulated deficit)(521)(422)(109)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.801.58(0.13)
Total equity1,3201,4181,552
Total liabilities & shareholders' equity2,3232,2032,107
Total common shares outstanding509509509
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.